Subtopic Deep Dive

Phloroglucinol Derivatives in Hypericum
Research Guide

What is Phloroglucinol Derivatives in Hypericum?

Phloroglucinol derivatives in Hypericum are bioactive polyphenolic compounds, primarily hyperforin, extracted from Hypericum perforatum used for antidepressant and pharmacological effects.

Hyperforin, a key phloroglucinol derivative, inhibits neuronal reuptake of neurotransmitters like glutamate and GABA (Wonnemann, 2000; 118 citations). These compounds contribute to St. John's wort efficacy in major depression, matching standard antidepressants with fewer side effects (Linde et al., 2008; 471 citations). Over 10 listed papers since 2000 document their mechanisms, with ~2,000 total citations.

Curated Papers

Key Challenges

Why It Matters

Phloroglucinol derivatives like hyperforin provide non-serotonergic antidepressant pathways via sodium channel modulation and uptake inhibition, supporting herbal treatments for major depression (Butterweck, 2003; Zanoli, 2004). They influence drug interactions by inducing CYP3A4, affecting clinical pharmacokinetics of co-administered drugs (Borrelli & Izzo, 2009; Russo et al., 2013). Applications extend to anti-angiogenic cancer effects and topical dermatological uses (Martínez-Poveda et al., 2005; Wölfle et al., 2013).

Key Research Challenges

Drug Interaction Prediction

Hyperforin induces CYP3A4, complicating co-administration with pharmaceuticals (Borrelli & Izzo, 2009; 274 citations). Clinical relevance persists despite updated observations (Nicolussi et al., 2019; 156 citations). Standardized prediction models are needed for safe herbal use.

Bioavailability Quantification

Phloroglucinol instability in extracts hinders precise bioavailability tracking (Russo et al., 2013; 175 citations). Pharmacokinetic studies reveal variable absorption (Butterweck, 2003). Advanced analytical methods are required for extract standardization.

Mechanism Specificity

Hyperforin inhibits multiple uptake systems via amiloride-sensitive pathways, blurring target specificity (Wonnemann, 2000; 118 citations). Distinguishing antidepressant from side effects remains unresolved (Zanoli, 2004). Receptor-level studies are limited.

Essential Papers

St John's wort for major depression

Klaus Linde, Michael M. Berner, Levente Kriston · 2008 · Cochrane Database of Systematic Reviews · 471 citations

The available evidence suggests that the hypericum extracts tested in the included trials a) are superior to placebo in patients with major depression; b) are similarly effective as standard antide...

Mechanism of Action of St John???s Wort in Depression

Veronika Butterweck · 2003 · CNS Drugs · 367 citations

Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations

Francesca Borrelli, Angelo A. Izzo · 2009 · The AAPS Journal · 274 citations

Topical Application of St. Johnʼs Wort (Hypericum perforatum)

Ute Wölfle, Günter Seelinger, Christoph M. Schempp · 2013 · Planta Medica · 206 citations

St. John's wort (Hypericum perforatum) has been intensively investigated for its antidepressive activity, but dermatological applications also have a long tradition. Topical St. John's wort prepara...

<i>Hypericum perforatum</i>: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug Interactions

Emilio Russo, Francesca Scicchitano, Benjamin J. Whalley et al. · 2013 · Phytotherapy Research · 175 citations

Hypericum perforatum (HP) belongs to the Hypericaceae family and is one of the oldest used and most extensively investigated medicinal herbs. The medicinal form comprises the leaves and flowering t...

Clinical relevance of St. John's wort drug interactions revisited

Simon Nicolussi, Jürgen Drewe, Veronika Butterweck et al. · 2019 · British Journal of Pharmacology · 156 citations

The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti‐depressant effects, interacting with other drugs, altering their bioavailability and effi...

Role of Hyperforin in the Pharmacological Activities of St. John's Wort

Paola Zanoli · 2004 · CNS Drug Reviews · 135 citations

ABSTRACT The phloroglucinol derivative hyperforin has been recently shown to be a major antidepressant component in the extract of Hypericum perforatum. Experimental studies clearly demonstrated it...

Reading Guide

Foundational Papers

Start with Linde et al. (2008; 471 citations) for clinical efficacy evidence, then Butterweck (2003; 367 citations) for mechanisms, and Zanoli (2004; 135 citations) for hyperforin specifics to build core understanding.

Recent Advances

Study Nicolussi et al. (2019; 156 citations) for updated interactions and Mullaicharam & Halligudi (2018; 79 citations) for chemistry synthesis.

Core Methods

Synaptosomal uptake assays measure neurotransmitter inhibition (Wonnemann, 2000); clinical trials assess depression outcomes (Linde et al., 2008); pharmacokinetic modeling tracks bioavailability (Russo et al., 2013).

How PapersFlow Helps You Research Phloroglucinol Derivatives in Hypericum

Discover & Search

Research Agent uses searchPapers and citationGraph to map 471-cited Linde et al. (2008) connections to hyperforin mechanisms, revealing clusters around Butterweck (2003) and Zanoli (2004). exaSearch uncovers extract-specific phloroglucinol biosynthesis papers beyond OpenAlex.

Analyze & Verify

Analysis Agent applies readPaperContent on Russo et al. (2013) for pharmacokinetic data extraction, then runPythonAnalysis with pandas to quantify CYP3A4 induction rates across Borrelli & Izzo (2009). verifyResponse (CoVe) and GRADE grading verify uptake inhibition claims from Wonnemann (2000) against contradictions.

Synthesize & Write

Synthesis Agent detects gaps in non-serotonergic pathways post-Butterweck (2003), flagging underexplored GABA modulation. Writing Agent uses latexEditText, latexSyncCitations for hyperforin review manuscripts, and exportMermaid to diagram biosynthesis-interaction workflows.

Use Cases

"Extract dose-response data for hyperforin uptake inhibition from key papers."

Research Agent → searchPapers('hyperforin synaptosomal uptake') → Analysis Agent → readPaperContent(Wonnemann 2000) → runPythonAnalysis(pandas curve fitting) → IC50 tables and matplotlib plots.

"Draft LaTeX review on phloroglucinol drug interactions in Hypericum extracts."

Synthesis Agent → gap detection(Borrelli 2009, Nicolussi 2019) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF) with interaction diagrams.

"Find code for Hypericum extract HPLC analysis from related papers."

Research Agent → paperExtractUrls(Russo 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect → validated Python scripts for phloroglucinol quantification.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ Hypericum papers, chaining citationGraph from Linde (2008) to extract efficacy meta-data into GRADE-graded reports. DeepScan applies 7-step analysis with CoVe checkpoints to verify hyperforin mechanisms in Wonnemann (2000) against clinical trials. Theorizer generates hypotheses on phloroglucinol biosynthesis gaps from Zanoli (2004).

Try Doxa for Phloroglucinol Derivatives in Hypericum Research

Frequently Asked Questions

What defines phloroglucinol derivatives in Hypericum?

Phloroglucinol derivatives are polyphenolic compounds like hyperforin from Hypericum perforatum, central to its antidepressant activity (Zanoli, 2004).

What are main analytical methods for these compounds?

HPLC tracks phloroglucinol stability in extracts; pharmacokinetic studies use mass spectrometry for bioavailability (Russo et al., 2013).

What are key papers on antidepressant mechanisms?

Linde et al. (2008; 471 citations) confirms efficacy; Butterweck (2003; 367 citations) details non-serotonergic action; Zanoli (2004; 135 citations) specifies hyperforin role.